Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Rubinstein, Maria M.
~ 1600  Ergebnisse:
englisch X
Personensuche X
?
1

Nivolumab for mismatch-repair-deficient or hypermutated gyn..:

Friedman, Claire F. ; Manning-Geist, Beryl L. ; Zhou, Qin...
Nature Medicine.  30 (2024)  5 - p. 1330-1338 , 2024
Link: https://doi.org/10.1038/..
 
?
2

Adverse events and oncologic outcomes with combination lenv..:

Zammarrelli III, William A. ; Ma, Weining ; Espino, Kevin...
Gynecologic Oncology.  178 (2023)  - p. 27-35 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Durvalumab with or without tremelimumab in patients with pe..:

Rubinstein, Maria M. ; Doria, Eric Rios ; Konner, Jason...
Gynecologic Oncology.  169 (2023)  - p. 64-69 , 2023
Link: https://doi.org/10.1016/..
 
?
4

A phase I open-label study of selinexor with paclitaxel and..:

Rubinstein, Maria M. ; Grisham, Rachel N. ; Cadoo, Karen...
Gynecologic Oncology.  160 (2021)  1 - p. 71-76 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Targeting obesity-related dysfunction in hormonally driven ..:

Rubinstein, Maria M. ; Brown, Kristy A. ; Iyengar, Neil M.
British Journal of Cancer.  125 (2021)  4 - p. 495-509 , 2021
Link: https://doi.org/10.1038/..
 
?
6

Baseline risk of hematologic malignancy at initiation of fr..:

Navitski, Anastasia ; Al-Rawi, Duaa H. ; Liu, Ying...
Gynecologic Oncology Reports.  38 (2021)  - p. 100873 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Sustained response to lenvatinib and pembrolizumab in two p..:

Shen, Sherry ; Rubinstein, Maria M. ; Park, Kay J...
Gynecologic Oncology Reports.  37 (2021)  - p. 100844 , 2021
Link: https://doi.org/10.1016/..
 
?
8

Bevacizumab in advanced endometrial cancer:

Rubinstein, Maria M. ; Dickinson, Shannan ; Narayan, Priyanka...
Gynecologic Oncology.  161 (2021)  3 - p. 720-726 , 2021
Link: https://doi.org/10.1016/..
 
?
9

Clinical outcomes of patients with POLE mutated endometrioi..:

Stasenko, Marina ; Tunnage, Irina ; Ashley, Charles W....
Gynecologic Oncology.  156 (2020)  1 - p. 194-202 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Management of thymoma‐associated pure red cell aplasia: A n..:

Rubinstein, Maria M. ; Goss, Cheryl ; Avecilla, Scott T....
Clinical Case Reports.  8 (2019)  2 - p. 289-292 , 2019
Link: https://doi.org/10.1002/..
 
?
11

Phase 2 study of LY3023414 in patients with advanced endome..:

Rubinstein, Maria M. ; Hyman, David M. ; Caird, Imogen...
Cancer.  126 (2019)  6 - p. 1274-1282 , 2019
Link: https://doi.org/10.1002/..
 
?
12

Durvalumab with or without tremelimumab in patients with pe..:

Rubinstein, Maria M ; Doria, Eric Rios ; Konner, Jason...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925401/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
13

Sustained response to lenvatinib and pembrolizumab in two p..:

Shen, Sherry ; Rubinstein, Maria M ; Park, Kay J..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365456/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
14

Targeting obesity-related dysfunction in hormonally driven ..:

Rubinstein, Maria M ; Brown, Kristy A ; Iyengar, Neil M
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368182/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
15

CLINICAL OUTCOMES OF PATIENTS WITH POLE MUTATED ENDOMETRIOI..:

Stasenko, Marina ; Tunnage, Irina ; Ashley, Charles W...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6980651/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
1-15